IP Library Granted Patent US 9,198,623
Granted Patent B2
US 9,198,623 · App. 13/091,557 · Granted Dec 1, 2015

Devices, systems, and methods related to analyte monitoring and management

Inventors: Jonathan Fern (Alameda, CA); Mark P. Jesser (Austin, TX); Lynn Dixon (Fremont, CA); Jai Karan (Fremont, CA); Charles Wei (Fremont, CA); Matthew T. Vogel (Oakland, CA); Tim S. Gasperak (Berkeley, CA); Kim Cullen (San Francisco, CA); Kim Ladin (Campbell, CA); Marc B. Taub (Mountain View, CA); Gary A. Hayter (Oakland, CA)
Assignee: Abbott Diabetes Care Inc.
A61B5/7475A61B5/0022A61B5/14532A61B5/743A61B5/7435A61B2560/0295A61B2560/045
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,198,623
App. No.
13/091,557
Granted
Dec 1, 2015
Kind
B2
Abstract

Analyte monitoring devices, systems, and methods are provided that relate to: enabling different application features on a data processing device for analyte monitoring devices with different analyte monitoring features; programming analyte monitoring devices in advance; personalizing an analyte monitoring device; graphically representing a remaining insulin level in a user body; and graphically representing analyte measurement related data for on-demand readings; protecting access to feature of an analyte monitoring device.

Claims (33)

1. A system for selectively displaying features of a first analyte monitoring device and a second analyte monitoring device, comprising:

a first analyte monitoring device having a first plurality of analyte monitoring features selected from performing blood glucose measurements, performing blood ketone measurements, performing carbohydrate measurements, performing bolus insulin calculations, performing basal insulin calculations, and performing device personalization;

a second analyte monitoring device having a second plurality of analyte monitoring features selected from performing blood glucose measurements, performing blood ketone measurements, performing carbohydrate measurements, performing bolus insulin calculations, performing basal insulin calculations, and performing device personalization, wherein the second plurality of analyte monitoring features include at least one analyte monitoring feature that is absent from the first plurality of analyte monitoring features;

a computer, comprising:

a display;

an interface to communicatively couple the computer with the first or second analyte monitoring device;

a processor; and

a non-transitory computer-readable medium comprising instructions that cause the processor to:

receive an indication that the first analyte monitoring device is communicatively coupled to the computer via the interface;

determine a first plurality of application features corresponding with the first plurality of analyte monitoring features for the first analyte monitoring device;

initiate a user interface application and display the first plurality of application features on the display;

receive an indication that the second analyte monitoring device is communicatively coupled to the computer via the interface;

determine a second plurality of application features corresponding with the second plurality of analyte monitoring features for the second analyte monitoring device, and the second plurality of application features:

(a) includes an application feature that is absent from the first plurality of application features, or

(b) does not include an application feature present in the first plurality of application features; and

modify the user interface application to display on the display the application feature that is absent from the first plurality of application features, if a determination is made that the second plurality of application features include an application feature that is absent from the first plurality of application features, or

modify the user interface application to no longer display on the display the application feature that is present in the first plurality of application features but not in the second plurality of application features, if a determination is made that the second plurality of application features does not include the application feature present in the first plurality of application features.

2. The computer of claim 1 , wherein the second plurality of application features does not include an application feature present in the first plurality of application features and the processor is programmed to:

modify the user interface application to no longer display the application feature that is present in the first plurality of application features absent in the second plurality of application features.

3. The computer of claim 1 , wherein the analyte is glucose.

4. The computer of claim 1 , wherein the first plurality of analyte monitoring features and the second plurality of analyte monitoring features include a feature for performing blood glucose measurements, and wherein the first plurality of application features and the second plurality of application features include a feature for displaying recorded blood glucose measurements.

5. The computer of claim 1 , wherein the at least one analyte monitoring feature that is absent comprises insulin calculation; and wherein the at least one application feature that is absent comprises enabling customization of device settings for insulin calculation.

6. The computer of claim 5 , wherein the insulin calculation is bolus calculation.

7. The computer of claim 5 , wherein the insulin calculation is basal calculation.

8. The computer of claim 1 , wherein the at least one analyte monitoring feature that is absent comprises ketone body measurement, and wherein the at least one application feature that is absent comprises displaying recorded ketone body measurements.

9. The computer of claim 1 , wherein the instructions cause the processor to:

receive an indication that a third analyte monitoring device is communicatively coupled to the computer via the interface, wherein the third analyte monitoring device includes a third plurality of analyte monitoring features, and wherein the third plurality of analyte monitoring features include at least one analyte monitoring feature that is absent from the first and second plurality of analyte monitoring features;

determine a third plurality of application features corresponding with the third plurality of analyte monitoring features for the third analyte monitoring device, and the third plurality of application features include at least one application feature that is absent from the first and second plurality of application features; and

modify the user interface application to display on the display the application feature that is absent from the first and second plurality of application features.

10. The computer of claim 9 , wherein the instructions cause the processor to:

modify the user interface application to no longer display on the display an application feature present in the first and second plurality of application features but absent in the third plurality of application features.

11. The computer of claim 1 , wherein the instructions cause the processor to:

activate an indicator on the first and the second analyte monitoring device, wherein the indicator indicates that the computer is communicatively coupled to the analyte monitoring device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2012
From: FERN, JONATHAN; JESSER, MARK P.; DIXON, LYNN; KARAN, JAI; WEI, CHARLES; VOGEL, MATTHEW T.; GASPERAK, TIMOTHY S.; CULLEN, KIM; LADIN, KIM; TAUB, MARC B.; HAYTER, GARY A.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 028785/0498 →
Continuity (2)
Provisional Application 61327023 · Apr 22, 2010
Related Publication 20110287528A1 · Nov 24, 2011